Format

Send to

Choose Destination
See comment in PubMed Commons below
J Biopharm Stat. 2010 Nov;20(6):1098-112. doi: 10.1080/10543406.2010.514447.

Perspectives on the use of adaptive designs in clinical trials. Part II. Panel discussion.

Author information

1
Federal Institute for Drugs and Medical Devices, Bonn, Germany.

Abstract

In the midst of gaining more experience in pursuing scientifically sound approaches of adaptive designs in clinical trials, a panel discussion with international representatives from industry, academia, and regulatory agencies was held at the Basel Biometric Society Spring Conference, March 12, 2010. The goal was to develop some consensus among industry, government, and academic statisticians concerning requirements and methods for adaptive designs in clinical trials. In this paper, we summarize the panelists' perspectives given at that session.

PMID:
21058105
DOI:
10.1080/10543406.2010.514447
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center